Home » CRN

Articles Tagged with ''CRN''

CRN Reacts to FDA's NDI Enforcement Discretion Draft Guidance

May 25, 2022

On May 19, the U.S. Food and Drug Administration has released a draft guidance outlining a proposed policy to give companies an opportunity to submit late new dietary ingredient (NDI) notifications. If finalized, the draft guidance will "advise the dietary supplement industry that FDA intends to exercise enforcement discretion, for a limited time...

AHPA: Mandatory Product Listing Could Cost Dietary Supplement Industry $20M

May 24, 2022

Maggie Jaqua, Content Director

Silver Spring, MD—Nearly $20 million. That's how much the dietary supplement industry will need to spend for initial compliance with the Dietary Supplement Listing Act of 2022, according to a study from the American Herbal Products Association (AHPA) that measured the time and associated costs to prepare product listings as...

Dietary Supplements Forum to Focus CBD, Mandatory Product Listings & More

May 2, 2022

WholeFoods Magazine Staff

UPDATE May 15, 2022: The Legal, Regulatory & Compliance Forum on Dietary Supplements on June 29-30, has moved from the Westin Grand Central to the InterContinental Times Square Hotel in New York City. New York, NY—The Council for Responsible Nutrition (CRN) and the American Conference Institute (ACI) have teamed up for Legal, Regulatory,...

Dietary Supplement Listing Act of 2022 Introduced; Industry Divided

April 27, 2022

Maggie Jaqua, Content Director

Washington, D.C.—The Dietary Supplement Listing Act of 2022 has been introduced by Senators Richard Durbin (D-IL) and Mike Braun (R-IN) with the intent of establishing a requirement for mandatory product listing (MPL) for all dietary supplements marketed in the United States. The aim of the bill, according to the authors:...

Remembering Senator Orrin G. Hatch, Dietary Supplement Industry Champion

April 25, 2022

WholeFoods Magazine Staff

Senator Orrin G. Hatch (R-Utah), who served in the Senate for seven terms before retiring in 2018, passed away on Saturday, April 23, at the age of 88. The New York Times reported that the cause was complications of a stroke suffered on April 15. The Hatch Foundation shared that Sen.

FDA Issuing Enforcement Discretion Guidance on NAC

April 21, 2022

Maggie Jaqua, Content Director

Washington, D.C.—The U.S. Food and Drug Administration (FDA) announced in a Constituent Update that it is issuing “Policy Regarding N-acetyl-L-cysteine: Draft Guidance for Industry” to be published on April 22, 2022. FDA said the draft guidance, when finalized, will explain the agency's intent to exercise enforcement discretion with respect to...

FDA Response on NAC Sets "Dangerous Precedent"

April 1, 2022

Maggie Jaqua, Content Director

Washington, D.C.—In July 2020, the U.S. Food and Drug Administration (FDA) sent warning letters to seven supplement companies selling products containing N-acetyl-L-cysteine (NAC), claiming that NAC was not lawful for sale as an ingredient in a dietary supplement because NAC had already been approved as a drug prior (in 1963)...

CRN Debunks Melatonin Myths

March 18, 2022

Julia Peterman

Washington, D.C.—In honor of National Sleep day (March 18), the Council for Responsible Nutrition (CRN) is debunking melatonin myths. According to CRN’s 2021 Consumer Survey on Dietary Supplements, 70% of supplement users regularly get a good night’s sleep, compared with 62% of non-users. The 2021 survey also indicated that 11%...

Article Calls for Military AER System; CRN Calls It "Counterproductive," "Wasteful"

February 16, 2022

Julia Peterman

A new article appearing in the Military Times is calling for an adverse event reporting system for military members, a concept which the Council for Responsible Nutrition (CRN) is calling “redundant.” The article states that “few people realize that many of these supplements contain ingredients that could make them dangerous...

Study Links Vit D, Omega-3 With Autoimmune Disease Risk Reduction

February 2, 2022

Julia Peterman

Vitamin D supplementation may reduce autoimmune disease incidence, according to a study published in BMJ. The study was part of VITAL (Vitamin D and Omega-3 trial), a five-year-long nationwide, randomized, double-blind, placebo-controlled trial, which included 25,871 participants. Participants were randomized into four groups: vitamin D treatment; vitamin D placebo; omega-3...